H. B. Fuller (NYSE:FUL) Updates FY 2026 Earnings Guidance

H. B. Fuller (NYSE:FUL) updated its FY 2026 earnings guidance on Wednesday. The company provided EPS guidance of 4.600-4.900 for the period, compared to the consensus estimate of 4.750. The company issued revenue guidance of -.

H. B. Fuller Price Performance

Shares of FUL opened at $61.94 on Friday. The stock has a market cap of $3.38 billion, a P/E ratio of 20.44, a price-to-earnings-growth ratio of 0.85 and a beta of 0.96. H. B. Fuller has a 1 year low of $48.71 and a 1 year high of $68.63. The stock’s 50-day moving average price is $61.60 and its two-hundred day moving average price is $61.28. The company has a current ratio of 1.92, a quick ratio of 1.15 and a debt-to-equity ratio of 1.01.

H. B. Fuller (NYSE:FUL) last announced its quarterly earnings results on Wednesday, June 24th. The specialty chemicals company reported $1.41 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.04. The company had revenue of $950.27 million during the quarter, compared to analysts’ expectations of $924.83 million. H. B. Fuller had a return on equity of 12.29% and a net margin of 5.29%.H. B. Fuller’s revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the business posted $1.18 EPS. H. B. Fuller has set its FY 2026 guidance at 4.600-4.900 EPS. On average, equities analysts predict that H. B. Fuller will post 4.78 earnings per share for the current year.

H. B. Fuller Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 14th. Investors of record on Thursday, April 30th were issued a dividend of $0.245 per share. This is an increase from H. B. Fuller’s previous quarterly dividend of $0.23. This represents a $0.98 dividend on an annualized basis and a yield of 1.6%. The ex-dividend date was Thursday, April 30th. H. B. Fuller’s dividend payout ratio is presently 32.34%.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on FUL shares. UBS Group upped their target price on shares of H. B. Fuller from $63.00 to $71.00 and gave the company a “neutral” rating in a research note on Wednesday, June 17th. Raymond James Financial set a $67.00 price target on shares of H. B. Fuller in a research report on Friday. Wall Street Zen raised shares of H. B. Fuller from a “hold” rating to a “buy” rating in a report on Sunday, March 29th. Citigroup upped their price objective on shares of H. B. Fuller from $67.00 to $70.00 and gave the company a “buy” rating in a research report on Monday, March 30th. Finally, JPMorgan Chase & Co. raised H. B. Fuller from an “underweight” rating to a “neutral” rating and set a $58.00 price objective on the stock in a research note on Wednesday, May 27th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, H. B. Fuller currently has an average rating of “Moderate Buy” and a consensus price target of $66.50.

Insiders Place Their Bets

In other H. B. Fuller news, CEO Celeste Beeks Mastin purchased 5,170 shares of the firm’s stock in a transaction dated Tuesday, April 7th. The stock was bought at an average cost of $57.08 per share, with a total value of $295,103.60. Following the purchase, the chief executive officer directly owned 8,670 shares of the company’s stock, valued at $494,883.60. The trade was a 147.71% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. 1.83% of the stock is currently owned by company insiders.

H. B. Fuller News Roundup

Here are the key news stories impacting H. B. Fuller this week:

• Positive Sentiment: H. B. Fuller reported second-quarter results that beat expectations, with EPS of $1.41 versus $1.37 consensus and revenue of $950.27 million versus $924.83 million estimated. The company also raised its FY2026 EPS guidance to $4.60-$4.90, supporting the case that core operations remain healthy. Article Title
• Neutral Sentiment: The company’s updated outlook was close to Wall Street’s expectations, which may limit how much of a positive reaction investors assign to the earnings beat alone.
• Negative Sentiment: Sentiment was pressured by H. B. Fuller’s agreement to buy Advanced Medical Solutions in a cash deal valued at about £715 million ($942 million), a transaction some investors view as aggressive and likely to add integration and financing risk. Article Title
• Negative Sentiment: Ancora publicly criticized the acquisition, calling it reckless and accusing management of ignoring shareholder opposition, which adds governance uncertainty and could weigh on the stock. Article Title
• Negative Sentiment: Investors are also digesting a new 10-K risk disclosure flagging “material emerging risks,” which can raise concerns about future volatility and execution risk. Article Title

Institutional Investors Weigh In On H. B. Fuller

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Aster Capital Management DIFC Ltd acquired a new position in shares of H. B. Fuller during the 4th quarter worth about $46,000. Brown Brothers Harriman & Co. bought a new stake in H. B. Fuller during the third quarter worth about $56,000. Advisory Services Network LLC bought a new stake in H. B. Fuller during the third quarter worth about $58,000. EverSource Wealth Advisors LLC boosted its position in H. B. Fuller by 129.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,218 shares of the specialty chemicals company’s stock valued at $73,000 after purchasing an additional 688 shares during the last quarter. Finally, Danske Bank A S acquired a new position in H. B. Fuller during the third quarter valued at approximately $77,000. 95.93% of the stock is owned by institutional investors.

H. B. Fuller Company Profile

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.